Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $96.1000 (0.47%) ($95.8500 - $97.4200) on Wed. Aug. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.36% (three month average) | RSI | 49 | Latest Price | $96.1000(0.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(50%) SPLV(39%) VYM(36%) DIA(34%) XLP(34%) | Factors Impacting ABBV price | ABBV will decline at least -0.68% in a week (0% probabilities). VIXM(-24%) UUP(-9%) VXX(-6%) TLT(-2%) EDOC(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.68% (StdDev 1.36%) | Hourly BBV | -0.1 () | Intraday Trend | -1% | | | |
|
5 Day Moving Average | $95.57(0.55%) | 10 Day Moving Average | $94.47(1.73%) | 20 Day Moving Average | $95.17(0.98%) | To recent high | -4.7% | To recent low | 6.8% | Market Cap | $169.548b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |